LSD-Assisted Therapy
MAPS has completed the first double-blind, placebo-controlled study of the therapeutic use of LSD in human beings since the early 1970s. LSD (lysergic acid diethylamide) is a semi-synthetic compound first …
Research
MDMA-Assisted Therapy Study Protocols
Phase 3 Trials: FDA Grants Breakthrough Therapy Designation for MDMA-Assisted Therapy for PTSD, Agrees on Special Protocol Assessment MAPS’ highest priority project is sponsoring Food and Drug Administration …
Other Psychedelic Research
See below for information about psychedelic research around the world not sponsored by MAPS. The studies listed here are limited to those in which psychedelics are administered to human subjects. Studies …
Ibogaine Therapy
MAPS has completed two observational studies of the long-term effects of ibogaine treatment on patients undergoing therapy at independent ibogaine treatment centers in Mexico and New Zealand. Image: Christopher …
Ayahuasca Research
MAPS supports research into the safety and effectiveness of ayahuasca-assisted treatment for drug addiction and PTSD. Banisteriopsis caapi We also support conferences, meetings, and publications about …
Medical Marijuana
MAPS has completed the first-ever clinical trial of smoked marijuana for symptoms of posttraumatic stress disorder (PTSD) in veterans of war. MAPS is working to demonstrate the safety and efficacy of smoked …